# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011859
Filing Date
2017-11-13
Accepted
2017-11-13 16:32:44
Documents
82
Period of Report
2017-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0917_immucellcorp.htm | 10-Q | 624145
2 | CERTIFICATION | f10q0917ex31_immucell.htm | EX-31 | 9593
3 | CERTIFICATION | f10q0917ex32_immucell.htm | EX-32 | 6002
| Complete submission text file | 0001213900-17-011859.txt |  | 5034968

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | iccc-20170930.xml | EX-101.INS | 1015961
5 | XBRL SCHEMA FILE | iccc-20170930.xsd | EX-101.SCH | 53516
6 | XBRL CALCULATION FILE | iccc-20170930_cal.xml | EX-101.CAL | 76214
7 | XBRL DEFINITION FILE | iccc-20170930_def.xml | EX-101.DEF | 126431
8 | XBRL LABEL FILE | iccc-20170930_lab.xml | EX-101.LAB | 514504
9 | XBRL PRESENTATION FILE | iccc-20170930_pre.xml | EX-101.PRE | 321479

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 171196407
SIC: 2835 In Vitro & In Vivo Diagnostic Substances